Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Journal of Vascular Surgery
|
July 4, 2002
The impact of the development of a program to reduce urgent (off-hours) venous duplex ultrasound scan studies
Eugene M Langan, Cindy B Coffey, Spence M Taylor, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2016
Optimization of amide-based EP3 receptor antagonists
Esther C Y Lee, Kentaro Futatsugi, Joel T Arcari, et al.
Plos One
|
November 15, 2018
Deuterium isotope effects in drug pharmacokinetics II: Substrate-dependence of the reaction mechanism influences outcome for cytochrome P450 cleared drugs
Hao Sun, David W Piotrowski, Suvi T M Orr, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 17, 2021
Discovery and evaluation of non-basic small molecule modulators of the atypical chemokine receptor CXCR7
Gary E Aspnes, Elnaz Menhaji-Klotz, Markus Boehm, et al.
Mbio
|
March 24, 2025
Storage of the vital metal tungsten in a dominant SCFA-producing human gut microbe <i>Eubacterium limosum</i> and implications for other gut microbes
Nana Shao, Dayong Zhou, Gerrit J Schut, et al.
Journal of Medicinal Chemistry
|
January 5, 2018
Identification of Morpholino-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-ones as Nonsteroidal Mineralocorticoid Antagonists
David W Piotrowski, Kentaro Futatsugi, Agustin Casimiro-Garcia, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 17, 2023
6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor
Gary E Aspnes, Scott W Bagley, Steven B Coffey, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 6, 2010
Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity
Kevin K-C Liu, Bruce A Lefker, Mark A Dombroski, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 28, 2023
Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups
Gary E Aspnes, Steven B Coffey, Etzer Darout, et al.
Journal of Medicinal Chemistry
|
June 8, 2018
Small Molecule Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Hit to Lead Optimization of Systemic Agents
Allyn T Londregan, Liuqing Wei, Jun Xiao, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Journal of Vascular Surgery
|
July 4, 2002
The impact of the development of a program to reduce urgent (off-hours) venous duplex ultrasound scan studies
Eugene M Langan, Cindy B Coffey, Spence M Taylor, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2016
Optimization of amide-based EP3 receptor antagonists
Esther C Y Lee, Kentaro Futatsugi, Joel T Arcari, et al.
Plos One
|
November 15, 2018
Deuterium isotope effects in drug pharmacokinetics II: Substrate-dependence of the reaction mechanism influences outcome for cytochrome P450 cleared drugs
Hao Sun, David W Piotrowski, Suvi T M Orr, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 17, 2021
Discovery and evaluation of non-basic small molecule modulators of the atypical chemokine receptor CXCR7
Gary E Aspnes, Elnaz Menhaji-Klotz, Markus Boehm, et al.
Mbio
|
March 24, 2025
Storage of the vital metal tungsten in a dominant SCFA-producing human gut microbe <i>Eubacterium limosum</i> and implications for other gut microbes
Nana Shao, Dayong Zhou, Gerrit J Schut, et al.
Journal of Medicinal Chemistry
|
January 5, 2018
Identification of Morpholino-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-ones as Nonsteroidal Mineralocorticoid Antagonists
David W Piotrowski, Kentaro Futatsugi, Agustin Casimiro-Garcia, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 17, 2023
6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor
Gary E Aspnes, Scott W Bagley, Steven B Coffey, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 6, 2010
Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity
Kevin K-C Liu, Bruce A Lefker, Mark A Dombroski, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 28, 2023
Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups
Gary E Aspnes, Steven B Coffey, Etzer Darout, et al.
Journal of Medicinal Chemistry
|
June 8, 2018
Small Molecule Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Hit to Lead Optimization of Systemic Agents
Allyn T Londregan, Liuqing Wei, Jun Xiao, et al.
Page
of 7